Conmed (CNMD) Net Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.00 |
| Dec 31, 2025 | -506.00 |
| Sep 30, 2025 | -203.00 |
| Jun 30, 2025 | 2,362.00 |
| Mar 31, 2025 | -89.00 |
| Dec 31, 2024 | 412.00 |
| Sep 30, 2024 | 1,248.00 |
| Jun 30, 2024 | 664.00 |
| Mar 31, 2024 | 584.00 |
| Dec 31, 2023 | 366.00 |
| Sep 30, 2023 | 232.00 |
| Jun 30, 2023 | 23.00 |
| Mar 31, 2023 | -466.00 |
| Dec 31, 2022 | -1,038.00 |
| Sep 30, 2022 | 1,299.00 |
| Jun 30, 2022 | -6,383.00 |
| Mar 31, 2022 | 862.00 |
| Dec 31, 2021 | 564.00 |
| Sep 30, 2021 | 204.00 |
| Jun 30, 2021 | 372.00 |
| Mar 31, 2021 | 549.00 |
| Dec 31, 2020 | 544.00 |
| Sep 30, 2020 | -236.00 |
| Jun 30, 2020 | -2,149.00 |
| Mar 31, 2020 | -78.00 |
| Dec 31, 2019 | -18.00 |
| Sep 30, 2019 | 186.00 |
| Jun 30, 2019 | -306.00 |
| Mar 31, 2019 | -427.00 |
| Dec 31, 2018 | 143.00 |
| Sep 30, 2018 | -29.00 |
| Jun 30, 2018 | -84.00 |
| Mar 31, 2018 | -34.00 |
| Dec 31, 2017 | 1,557.00 |
| Sep 30, 2017 | -134.00 |
| Jun 30, 2017 | -231.00 |
| Mar 31, 2017 | -757.00 |
| Dec 31, 2016 | 1,683.00 |
| Sep 30, 2016 | -78.00 |
| Jun 30, 2016 | -325.00 |
| Mar 31, 2016 | -615.00 |
| Dec 31, 2015 | 33.00 |
| Sep 30, 2015 | 16.00 |
| Jun 30, 2015 | 9.00 |